SGLT2 inhibitors: What role do they play in heart failure with reduced ejection fraction?

Abstract: Sodium-glucose cotransporter-2 (SGLT2) inhibitors can decrease risk for heart failure in patients with type 2 diabetes and can decrease risk of major cardiovascular events in patients with heart failure (HF) and diabetes. Specific SGLT2 inhibitors can also decrease major cardiovascular events in patients with HF only.
Source: The Nurse Practitioner - Category: Nursing Tags: Feature: HEART FAILURE: NCPD Connection Source Type: research